|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.48 HKD | -5.61% |
|
-11.54% | -55.77% |
| 06-26 | Cf Pharmtech, Inc. Announces Board and Supervisor Appointments, Effective June 26, 2026 | CI |
| 06-05 | CF PharmTech Clears GMP Inspection for Suzhou Inhalation Drug Facility | MT |
| Market Cap | 5.5B 6.36B 812M 709M 654M 603M 1.14B 78.15B 1.16B 7.82B 3.08B 38.28B 3.05B 2.98B 132B | P/E 2024 * |
-
| P/E 2025 | 4,780x |
|---|---|---|---|---|---|
| Enterprise Value | 4.99B 5.77B 736M 643M 594M 547M 1.03B 70.9B 1.05B 7.1B 2.79B 34.72B 2.76B 2.7B 120B | EV / Sales 2024 * |
-
| EV / Sales 2025 | 28.8x |
| Free-Float |
33.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -5.61% | ||
| 1 week | -11.54% | ||
| Current month | -26.29% | ||
| 1 month | -17.57% | ||
| 3 months | -32.64% | ||
| 6 months | -53.57% | ||
| Current year | -55.77% |
| 1 week | 15.3 |  | 18.04 |
| 1 month | 15.3 | | 21.2 |
| Current year | 15.3 | | 39.5 |
| 1 year | 15.3 | | 48.8 |
| 3 years | 15.3 | | 48.8 |
| 5 years | 15.3 | | 48.8 |
| 10 years | 15.3 | | 48.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wen Qing Liang
CEO | Chief Executive Officer | 60 | 2006-12-31 |
Li Li
CTO | Chief Tech/Sci/R&D Officer | 67 | 2020-08-31 |
Wei Wei
DFI | Director of Finance/CFO | 47 | 2021-11-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Li Li
BRD | Director/Board Member | 67 | 2020-08-31 |
Wen Qing Liang
CHM | Chairman | 60 | 2006-12-31 |
Qi Li
BRD | Director/Board Member | 67 | 2020-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/22/25 | Other | Founder | 6,500 | 0.0022% | ||
| 12/22/25 | Other | Chief Executive Officer | 6,500 | 0.0022% | ||
| 12/19/25 | Other | Chief Executive Officer | 5,000 | 0.0017% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.61% | -11.54% | - | - | 812M | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | |
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | |
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | |
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | |
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | |
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | |
| Average | -0.62% | -0.67% | +28.54% | +53.91% | 357.59B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +79.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 608M 703M 89.66M 78.36M 72.3M 66.65M 126M 8.63B 128M 864M 340M 4.23B 337M 329M 14.56B | 433M 500M 63.81M 55.76M 51.46M 47.43M 89.4M 6.15B 91.38M 615M 242M 3.01B 240M 234M 10.36B |
| Net income | 21.09M 24.39M 3.11M 2.72M 2.51M 2.31M 4.36M 300M 4.46M 29.99M 11.79M 147M 11.68M 11.43M 505M | 2.48M 2.87M 367K 320K 296K 273K 514K 35.31M 525K 3.53M 1.39M 17.29M 1.38M 1.35M 59.52M |
| Net Debt | -275M -318M -40.57M -35.46M -32.72M -30.16M -56.84M -3.91B -58.1M -391M -154M -1.91B -152M -149M -6.59B | -511M -591M -75.34M -65.84M -60.75M -56M -106M -7.26B -108M -726M -286M -3.55B -283M -277M -12.23B |
Employees
540
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | HK$15.48 | -5.61% | 574,500 |
| 26-07-16 | HK$16.40 | -3.81% | 683,400 |
| 26-07-15 | HK$17.05 | -0.76% | 365,100 |
| 26-07-14 | HK$17.18 | -1.88% | 652,400 |
| 26-07-13 | HK$17.51 | +0.06% | 422,500 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2652 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
